成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart 0 Sign in  

[ CAS No. 188614-01-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 188614-01-9
Chemical Structure| 188614-01-9
Structure of 188614-01-9 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 188614-01-9 ]

Related Doc. of [ 188614-01-9 ]

Alternatived Products of [ 188614-01-9 ]
Product Citations

Product Details of [ 188614-01-9 ]

CAS No. :188614-01-9 MDL No. :MFCD00449104
Formula : C10H9NO3S Boiling Point : No data available
Linear Structure Formula :- InChI Key :UFSVRHNRNVVBJR-UHFFFAOYSA-N
M.W : 223.25 Pubchem ID :699501
Synonyms :

Calculated chemistry of [ 188614-01-9 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 15
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.2
Num. rotatable bonds : 2
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 59.77
TPSA : 80.7 ?2

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.76 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.92
Log Po/w (XLOGP3) : 1.27
Log Po/w (WLOGP) : 0.95
Log Po/w (MLOGP) : 1.29
Log Po/w (SILICOS-IT) : 1.89
Consensus Log Po/w : 1.46

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.19
Solubility : 1.45 mg/ml ; 0.00648 mol/l
Class : Soluble
Log S (Ali) : -2.56
Solubility : 0.61 mg/ml ; 0.00273 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.08
Solubility : 0.184 mg/ml ; 0.000826 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.24

Safety of [ 188614-01-9 ]

Signal Word:Warning Class:
Precautionary Statements:P261-P305+P351+P338 UN#:
Hazard Statements:H302-H315-H319-H335 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 188614-01-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 188614-01-9 ]
  • Downstream synthetic route of [ 188614-01-9 ]

[ 188614-01-9 ] Synthesis Path-Upstream   1~4

  • 1
  • [ 2365-48-2 ]
  • [ 412947-54-7 ]
  • [ 188614-01-9 ]
YieldReaction ConditionsOperation in experiment
90% With copper(l) iodide; (R,R)-N,N'-dimethyl-1,2-diaminocyclohexane; caesium carbonate In 1,4-dioxane at 100℃; Inert atmosphere General procedure: a suspension of 3-iodo-4-aminopyridine (1 mmol), methyl 2-mercaptoacetate (1.5 equiv), copper (I) iodide (0.05 mmol), trans-N,N'-dimethylcyclohexane-1,2-diamine (0.1 mmol) and cesium carbonate(2 equiv) in dry 1,4-dioxane (4 mL) in a vial was degassed by bubbling N2 into the suspension for 3 min while stirring. The vial was then capped tightly. The mixture was heated at 100 C (oil bath temperature) for 15 h. After coolingto rt, filtration was carried out. The combined filtrates were concentrated on rotavap and the residue was subjected to silica gel column chromatographpurification (5percent methanol in methylene chloride) furnishing 3b as a beige solid.
Reference: [1] Tetrahedron Letters, 2013, vol. 54, # 38, p. 5214 - 5216
  • 2
  • [ 188614-00-8 ]
  • [ 188614-01-9 ]
Reference: [1] Journal of Medicinal Chemistry, 2012, vol. 55, # 16, p. 7262 - 7272
  • 3
  • [ 453-71-4 ]
  • [ 188614-01-9 ]
Reference: [1] Journal of Medicinal Chemistry, 2012, vol. 55, # 16, p. 7262 - 7272
  • 4
  • [ 329-59-9 ]
  • [ 188614-01-9 ]
Reference: [1] Journal of Medicinal Chemistry, 2012, vol. 55, # 16, p. 7262 - 7272
Recommend Products
Same Skeleton Products

Technical Information

Historical Records

Related Functional Groups of
[ 188614-01-9 ]

Amides

Chemical Structure| 440627-14-5

[ 440627-14-5 ]

11-Oxo-10,11-dihydrodibenzo[b,f][1,4]thiazepine-8-carboxylic acid

Similarity: 0.73

Chemical Structure| 22288-79-5

[ 22288-79-5 ]

Methyl 3-acetamidothiophene-2-carboxylate

Similarity: 0.68

Chemical Structure| 1628-29-1

[ 1628-29-1 ]

1-(10H-Phenothiazin-10-yl)ethanone

Similarity: 0.68

Chemical Structure| 4093-28-1

[ 4093-28-1 ]

Methyl 4-acetamido-2-hydroxybenzoate

Similarity: 0.63

Chemical Structure| 3814-10-6

[ 3814-10-6 ]

Methyl 4-(phenylcarbamoyl)benzoate

Similarity: 0.63

Esters

Chemical Structure| 73931-63-2

[ 73931-63-2 ]

Methyl benzo[d]thiazole-6-carboxylate

Similarity: 0.70

Chemical Structure| 131707-24-9

[ 131707-24-9 ]

Ethyl 6-bromo-5-hydroxy-1-methyl-2-((phenylthio)methyl)-1H-Indole-3-carboxylate

Similarity: 0.70

Chemical Structure| 22288-79-5

[ 22288-79-5 ]

Methyl 3-acetamidothiophene-2-carboxylate

Similarity: 0.68

Chemical Structure| 1190320-40-1

[ 1190320-40-1 ]

Methyl 4-methylbenzo[d]thiazole-6-carboxylate

Similarity: 0.66

Chemical Structure| 1038509-28-2

[ 1038509-28-2 ]

Methyl benzo[d]thiazole-7-carboxylate

Similarity: 0.66

Related Parent Nucleus of
[ 188614-01-9 ]

Other Aromatic Heterocycles

Chemical Structure| 3598-37-6

[ 3598-37-6 ]

1-(10-(3-(Dimethylamino)propyl)-10H-phenothiazin-2-yl)ethan-1-one maleate

Similarity: 0.74

Chemical Structure| 440627-14-5

[ 440627-14-5 ]

11-Oxo-10,11-dihydrodibenzo[b,f][1,4]thiazepine-8-carboxylic acid

Similarity: 0.73

Chemical Structure| 6631-94-3

[ 6631-94-3 ]

1-(10H-Phenothiazin-2-yl)ethanone

Similarity: 0.70

Chemical Structure| 1628-29-1

[ 1628-29-1 ]

1-(10H-Phenothiazin-10-yl)ethanone

Similarity: 0.68

Chemical Structure| 82782-85-2

[ 82782-85-2 ]

Methyl 4H-thieno[3,2-b]pyrrole-5-carboxylate

Similarity: 0.66

; ;